Embolization of Middle Meningeal Artery in Chronic Subdural Hematoma

Recruiting N/A Interventional Study
Chronic Subdural Hematomas
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 – 90
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
170 (estimated)
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Chronic subdural hematoma (cSDH) is a common neurological affliction which affects mostly frail and elderly patients. Surgical evacuation by using burr hole craniostomy (BHC) is the most frequently used treatment but carries a recurrence rate varying between 10-30% in the literature. Especially in this frail population re-operation is undesirable. Embolization of the middle meningeal artery is an …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * · CT-confirmed diagnosis of chronic Subdural Hematoma; * Primary surgical treatment based on clinical symptoms (progressive neurological deficits). Exclusion Criteria: * · Significant contraindication to angiography (eg. allergy for contrast); * Structural causes for s…
Contacts

Dagmar Verbaan, PhD

+31205663316

d.verbaan@amsterdamumc.nl

CONTACT

R. van den Berg, MD PhD

+31205669111

r.vdberg@amsterdamumc.nl

CONTACT